Holen Sie sich die Stockscreener-App
13.50
1.12%
0.15
Handel nachbörslich:
13.50
Schlusskurs vom Vortag:
$13.35
Offen:
$13.42
24-Stunden-Volumen:
136.55K
Relative Volume:
1.13
Marktkapitalisierung:
$591.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.74%
1M Leistung:
-15.68%
6M Leistung:
+12.50%
1J Leistung:
+0.00%
1-Tages-Spanne:
$12.86
$13.58
1-Wochen-Bereich:
$12.86
$14.56
52-Wochen-Spanne:
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
Firmenname
Maze Therapeutics Inc
Sektor
Branche
Telefon
(650) 850-5070
Adresse
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Vergleichen Sie MAZE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
13.50 | 595.64M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-08 | Eingeleitet | Wedbush | Outperform |
Maze Therapeutics Inc Aktie (MAZE) Neueste Nachrichten
How Maze Therapeutics Inc. stock performs during market volatility2025 Trading Volume Trends & High Accuracy Trade Signal Alerts - newsyoung.net
Maze Therapeutics: Promising Future with Strong Pipeline and Robust Financial Health - TipRanks
Maze Therapeutics Plunges 17.08% Despite Beating EPS Estimates - AInvest
Why Maze Therapeutics Inc. stock attracts strong analyst attentionPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
Should you wait for a breakout in Maze Therapeutics Inc.Quarterly Portfolio Report & Entry and Exit Point Strategies - Newser
Risk adjusted return profile for Maze Therapeutics Inc. analyzed2025 Price Momentum & AI Enhanced Trading Alerts - Newser
RSI Divergence May Trigger a Bounce in Maze Therapeutics Inc.July 2025 Levels & Expert Curated Trade Setups - newsyoung.net
Is it time to cut losses on Maze Therapeutics Inc.2025 Key Lessons & Real-Time Buy Zone Alerts - Newser
Institutional scanner results for Maze Therapeutics Inc.Gap Up & High Accuracy Investment Signals - Newser
Maze Therapeutics reports Q2 EPS (77c), consensus ($1.15) - MSN
Maze Therapeutics, Inc.: Buy Rating Backed by Promising Clinical Developments and Strategic Trials - TipRanks
What’s the recovery path for long term holders of Maze Therapeutics Inc.Quarterly Portfolio Summary & Weekly High Return Stock Opportunities - Newser
Maze Therapeutics: Promising Innovations in PKU and CKD Treatment with MZE782 - TipRanks
Using data models to predict Maze Therapeutics Inc. stock movement - Newser
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - GlobeNewswire
How to escape a deep drawdown in Maze Therapeutics Inc.Free Real Market Momentum Signal Generator - Newser
Will Maze Therapeutics Inc. stock recover after earningsExploding Volume High ROI Picks - newsyoung.net
When is the best time to exit Maze Therapeutics Inc.Technical Chart Summary for Momentum Stocks - Newser
Published on: 2025-08-12 08:41:52 - Newser
Will a bounce in Maze Therapeutics Inc. offer an exitBuy and Hold Strategy for Capital Safety - Newser
What moving averages say about Maze Therapeutics Inc.Profit Target Planning with Exit Confidence - Newser
How to build a custom watchlist for Maze Therapeutics Inc.Real Market Tracker with Price Action Tools - Newser
What makes Maze Therapeutics Inc. stock price move sharplyStock Entry Point Planner with Volume Spike - Newser
Visual trend scoring systems applied to Maze Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Real time pattern detection on Maze Therapeutics Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
Bank of New York Mellon Corp Makes New Investment in Maze Therapeutics, Inc. (NASDAQ:MAZE) - Defense World
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $25.60 Average Price Target from Analysts - Defense World
How does Maze Therapeutics Inc. compare to its industry peersFast-track wealth growth - Jammu Links News
What are the technical indicators suggesting about Maze Therapeutics Inc.Invest confidently with real-time market updates - Jammu Links News
Finanzdaten der Maze Therapeutics Inc-Aktie (MAZE)
Es liegen keine Finanzdaten für Maze Therapeutics Inc (MAZE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):